GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Extendicare Inc (OTCPK:EXETF) » Definitions » Forward Rate of Return (Yacktman) %
中文

Extendicare (Extendicare) Forward Rate of Return (Yacktman) % : -4.43% (As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Extendicare Forward Rate of Return (Yacktman) %?

Yacktman defines forward rate of return as the normalized free cash flow yield plus real growth plus inflation. Extendicare's forward rate of return for was -4.43%.

The historical rank and industry rank for Extendicare's Forward Rate of Return (Yacktman) % or its related term are showing as below:

EXETF' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -15.31   Med: -5.56   Max: 4.59
Current: -4.43

During the past 13 years, Extendicare's highest Forward Rate of Return was 4.59. The lowest was -15.31. And the median was -5.56.

EXETF's Forward Rate of Return (Yacktman) % is ranked worse than
86.54% of 312 companies
in the Healthcare Providers & Services industry
Industry Median: 15.22 vs EXETF: -4.43

Unlike the Earnings Yield %, the Forward Rate of Return uses the normalized Free Cash Flow of the past seven years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.


Extendicare Forward Rate of Return (Yacktman) % Historical Data

The historical data trend for Extendicare's Forward Rate of Return (Yacktman) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Extendicare Forward Rate of Return (Yacktman) % Chart

Extendicare Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Forward Rate of Return (Yacktman) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.13 -0.96 3.18 -3.33 -4.43

Extendicare Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Forward Rate of Return (Yacktman) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.33 -5.98 -6.81 -6.88 -4.43

Competitive Comparison of Extendicare's Forward Rate of Return (Yacktman) %

For the Medical Care Facilities subindustry, Extendicare's Forward Rate of Return (Yacktman) %, along with its competitors' market caps and Forward Rate of Return (Yacktman) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Extendicare's Forward Rate of Return (Yacktman) % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Extendicare's Forward Rate of Return (Yacktman) % distribution charts can be found below:

* The bar in red indicates where Extendicare's Forward Rate of Return (Yacktman) % falls into.



Extendicare Forward Rate of Return (Yacktman) % Calculation

Forward Rate of Return is a concept that Don Yacktman uses in his investment approach. Yacktman explained the forward rate of return concept in detail in his interview with GuruFocus. Yacktman defines forward rate of return as the normalized free cash flow yield plus real growth plus inflation. He said in the interview (March 2012, when the S&P 500 was at about 1400):

If the business is stable, this calculation is fairly straightforward. For instance, on the S&P 500 we would normalize earnings. We would then calculate what percentage of those earnings are not reinvested in the underlying businesses and are therefore free. Historically, for the S&P 500, this has been just under 50% of earnings. Currently, we expect the S&P to earn about 70 on a normalized basis, a number which is far below reported earnings due to our adjusting for record high profit margins. $70 X ½ / 1400 gives you a normalized free cash flow yield of approximately 2.5%.

The historical real growth rate of the S&P 500 (companies) is about 1.5%. Assuming an inflation rate of 2.5%, the forward rate of return on an investment in the S&P 500 is about 6.5% today (2.5% free cash flow yield plus 1.5% real growth plus 2.5% inflation).

Extendicare's Forward Rate of Return of Dec. 2023 is

Forward Rate of Return=Normalized Free Cash Flow/Price+5-Year EBITDA Growth Rate
=-0.05638095/5.494+-0.0321
=-4.24 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Extendicare  (OTCPK:EXETF) Forward Rate of Return (Yacktman) % Explanation

Unlike the Earnings Yield, the Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.

For the growth part of the Forward Rate of Return calculation, GuruFocus uses the 5-year average growth rate of EBITDA per share as the growth rate, and the growth rate is always capped at 20%. For the Free Cash Flow we use per share data averaged over five years. The reason we use five years is to make it comparable to the growth rate.


Be Aware

In the Forward Rate of Return calculation, the growth rate is added directly to today's free cash flow yield. Therefore the calculation is reliable only if the company can grow at the same rate in the future as it did in the past. Investors should pay close attention to this when researching growth stocks. A more accurate measurement for return is Return on Capital.


Extendicare Forward Rate of Return (Yacktman) % Related Terms

Thank you for viewing the detailed overview of Extendicare's Forward Rate of Return (Yacktman) % provided by GuruFocus.com. Please click on the following links to see related term pages.


Extendicare (Extendicare) Business Description

Traded in Other Exchanges
Address
3000 Steeles Avenue East, Suite 700, Markham, ON, CAN, L3R 9W2
Extendicare Inc is a senior care provider in Canada, focused on long-term care and home health care. The company has three main business segments namely Long-term Care, Home Health Care, and Managed Services. The Long-term Care segment, operating under the Extendicare brand, represents 53 owned homes in Ontario, Alberta and Manitoba. The Home Health Care segment, operating under the ParaMed brand, provides more than 9 million hours of home health care services annually in Ontario, Alberta, Manitoba and Nova Scotia. The Managed Services segment, operating under the Extendicare Assist and SGP Purchasing Partner Network brands, provides management, consulting and group purchasing services to other care providers across Canada.

Extendicare (Extendicare) Headlines

From GuruFocus

Extendicare Announces December 2018 Dividend of C$0.04 per Share

By GlobeNewswire GlobeNewswire 12-14-2018

Extendicare Provides Business Update Related to COVID-19

By GlobeNewswire GlobeNewswire 04-28-2020

Extendicare Announces December 2020 Dividend of C$0.04 per Share

By GlobeNewswire GlobeNewswire 12-17-2020

Extendicare Completes Acquisition of Lynde Creek Retirement Community

By GlobeNewswire GlobeNewswire 04-11-2018

Extendicare Announces Normal Course Issuer Bid

By GlobeNewswire GlobeNewswire 06-27-2022

Extendicare Appoints Dr. Michael R. Guerriere as New President and CEO

By GlobeNewswire GlobeNewswire 09-11-2018

Extendicare Announces December 2019 Dividend of C$0.04 per Share

By GlobeNewswire GlobeNewswire 12-12-2019